share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E

艾伯維公司 | 4：持股變動聲明-董事 Quaggin Susan E
美股sec公告 ·  05/07 18:36
Moomoo AI 已提取核心訊息
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
On May 3, 2024, Susan E Quaggin, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. The transaction, which was completed on the same day, increased Quaggin's direct holdings in the company to a total of 1,322 shares. The shares granted are of $0.01 par value each, and the grant signifies a direct acquisition of equity in the pharmaceutical company.
2024年5月3日，與艾伯維公司 [ABBV] 關聯的蘇珊·誇金免費獲得了1,322股普通股。該交易於同日完成，使Quaggin在該公司的直接持股量增加到1,322股。授予的每股股票面值爲0.01美元，贈款表示直接收購該製藥公司的股權。
2024年5月3日，與艾伯維公司 [ABBV] 關聯的蘇珊·誇金免費獲得了1,322股普通股。該交易於同日完成，使Quaggin在該公司的直接持股量增加到1,322股。授予的每股股票面值爲0.01美元，贈款表示直接收購該製藥公司的股權。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息